Sales and Marketing

Showing 15 posts of 11527 posts found.

MPs concerned about care.data

February 27, 2014 Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data

MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …

Novartis to axe Horsham site

February 27, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

Biotech industry failed by UK, says UCB

February 27, 2014 Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat

The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …

Best of Health Awards judges appointed

February 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson

The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …

Mid Staffs to be ‘dissolved’

February 27, 2014 Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas

The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …

InterMune scores in lung trial

February 26, 2014 Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014 Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …

Bupa hires MHP Health head

February 26, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health

Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …

Lilly’s diabetes drug matches Victoza

February 26, 2014 Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly

Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …

Samsung focussing increasingly on health tech

February 25, 2014 Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch

Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …

UCB names next chief executive

February 25, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier

Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …

NICE restricts Yervoy use

February 25, 2014 Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …

FDA given $20 million for generic testing

February 24, 2014 Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

Europe poised for generic Symbicort

February 24, 2014 Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014 Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
The Gateway to Local Adoption Series

Latest content